The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination.
CD44
MMT
colorectal cancer
mesothelial cells
peritoneal carcinomatosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 May 2021
20 May 2021
Historique:
received:
19
04
2021
revised:
12
05
2021
accepted:
14
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Advanced colorectal cancer (CRC) is highly metastatic and often results in peritoneal dissemination. The extracellular vesicles (EVs) released by cancer cells in the microenvironment are important mediators of tumor metastasis. We investigated the contribution of EV-mediated interaction between peritoneal mesothelial cells (MCs) and CRC cells in generating a pro-metastatic environment in the peritoneal cavity. Peritoneal MCs isolated from peritoneal lavage fluids displayed high CD44 expression, substantial mesothelial-to-mesenchymal transition (MMT) and released EVs that both directed tumor invasion and caused reprogramming of secretory profiles by increasing TGF-β1 and uPA/uPAR expression and MMP-2/9 activation in tumor cells. Notably, the EVs released by tumor cells induced apoptosis by activating caspase-3, peritoneal MC senescence, and MMT, thereby augmenting the tumor-promoting potential of these cells in the peritoneal cavity. By using pantoprazole, we reduced the biogenesis of EVs and their pro-tumor functions. In conclusion, our findings provided evidence of underlying mechanisms of CRC dissemination driven by the interaction of peritoneal MCs and tumor cells via the EVs released in the peritoneal cavity, which may have important implications for the clinical management of patients.
Identifiants
pubmed: 34065529
pii: cancers13102505
doi: 10.3390/cancers13102505
pmc: PMC8161093
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Regione Puglia
ID : Tecnopolo per la Medicina di Precisione (CUP B84I1800054002)
Organisme : Regione Puglia
ID : Carcinosi Peritoneale (Del. 768/18)
Références
Mol Cancer. 2019 Aug 13;18(1):124
pubmed: 31409361
Perit Dial Int. 2019 Jan-Feb;39(1):35-41
pubmed: 30478141
Int J Biochem Cell Biol. 2017 May;86:26-31
pubmed: 28323210
Curr Protoc Stem Cell Biol. 2019 Feb;48(1):e76
pubmed: 30624011
PLoS One. 2013 Jul 11;8(7):e68117
pubmed: 23874518
Ann Surg. 2006 Feb;243(2):212-22
pubmed: 16432354
Mol Cancer Res. 2017 Jan;15(1):78-92
pubmed: 27758876
Cancer Lett. 2019 Feb 1;442:181-192
pubmed: 30429105
Int J Mol Sci. 2020 Jul 23;21(15):
pubmed: 32718103
Cancers (Basel). 2019 Mar 07;11(3):
pubmed: 30866547
PLoS One. 2012;7(11):e50342
pubmed: 23226264
J Cell Biol. 2018 Aug 6;217(8):2891-2910
pubmed: 29884750
J Extracell Vesicles. 2019 Apr 01;8(1):1596016
pubmed: 30988894
J Clin Invest. 2014 Oct;124(10):4614-28
pubmed: 25202979
PLoS One. 2013;8(2):e57659
pubmed: 23451255
World J Gastroenterol. 2016 Sep 14;22(34):7692-707
pubmed: 27678351
Int J Cancer. 2010 Jul 15;127(2):293-303
pubmed: 19904754
EJC Suppl. 2020 Aug 22;15:38-48
pubmed: 33240441
J Cell Biol. 2018 Aug 6;217(8):2613-2614
pubmed: 29976599
Sci Rep. 2020 Jun 26;10(1):10465
pubmed: 32591592
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Int J Clin Pharmacol Ther. 1996 May;34(5):185-94
pubmed: 8738854
BMC Cancer. 2017 Mar 24;17(1):215
pubmed: 28340565
Nat Methods. 2017 Feb 28;14(3):228-232
pubmed: 28245209
Biomed Pharmacother. 2021 Jan;133:111006
pubmed: 33202284
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Cancer. 2000 Oct 25;90(5):299-306
pubmed: 11038427
J Pathol. 2017 Jun;242(2):140-151
pubmed: 28247413
FEBS Lett. 2020 Dec;594(24):4233-4246
pubmed: 32239503
Nat Commun. 2017 Mar 06;8:14470
pubmed: 28262727
Arthritis Rheum. 2013 Jan;65(1):258-69
pubmed: 22972461
J Oncol. 2019 Sep 19;2019:7407190
pubmed: 31641356
Cancers (Basel). 2020 Feb 21;12(2):
pubmed: 32098058
Cancer Res. 2013 Sep 1;73(17):5347-59
pubmed: 23838935
Cell Death Dis. 2019 Jan 10;10(1):30
pubmed: 30631039
Methods Mol Biol. 2017;1660:143-152
pubmed: 28828654
Science. 2019 Dec 20;366(6472):1473-1480
pubmed: 31699882
Cell Mol Life Sci. 2021 Mar;78(6):3057-3072
pubmed: 33237352
Cancer Cell Int. 2018 Sep 10;18:137
pubmed: 30214379
Oncotarget. 2015 Oct 6;6(30):29178-95
pubmed: 26284488
Front Cell Dev Biol. 2017 Mar 07;5:18
pubmed: 28326306
Cell Death Dis. 2016 Dec 29;7(12):e2565
pubmed: 28032864
PLoS One. 2015 Jul 24;10(7):e0130472
pubmed: 26208314
J Transl Med. 2019 Jun 20;17(1):208
pubmed: 31221189
Cell Mol Life Sci. 2018 Feb;75(3):509-525
pubmed: 28956065
FEBS Lett. 2017 Jul;591(14):2167-2179
pubmed: 28643334
Breast Cancer Res. 2012 May 23;14(3):R84
pubmed: 22621373